Cardiac Involvement in COVID-19
Guest: Patricia A. Pellikka, M.D. (@pattypellikka)
Host: Paul A. Friedman, M.D. (@drpaulfriedman)
Early reports from Wuhan, China, noted that patients with underlying cardiovascular disease had a higher risk of morbidity and mortality if they contracted the COVID-19 virus. More recently, data support that patients with evidence of cardiac disease during their COVID-19 episodes also have higher rates of morbidity and mortality during hospitalization for treatment of COVID-19.
Joining us today to discuss the cardiac involvement in patients with COVID-19 is Patricia A. Pellikka, M.D., vice chair of Cardiovascular Medicine at Mayo Clinic in Rochester, Minnesota.
Specific topics discussed:
- Significance of cardiac involvement in patients with COVID-19
- Diagnosis of cardiac dysfunction in patients with COVID-19
- Myocarditis and other cardiac injury in patients with COVID-19
- Implications of MRI-identified myocarditis
- COVID-19 long-haulers and cardiac evaluation
- Artificial intelligence in electrocardiogram or echocardiogram
Connect with Mayo Clinic's Cardiovascular Continuing Medical Education online at https://cveducation.mayo.edu or on Twitter @MayoClinicCV.
No CME credit offered for this episode.
Podcast episode transcript here.
